...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM thoughts
5
Nov 28, 2017 03:59PM
3
Nov 28, 2017 06:38PM
4
Nov 28, 2017 10:48PM

I am wondering why we have not heard a peep regarding the $10 mill PP which was supposedly to occur very shortly as per the comment at the last bio conference  Zenith presented in Oct or early November,  Did the PP get postponed for other reasons that maybe  more beneficial to all shareholders.....

 

I am surprised with that a major BP has not released on any type of  the trigger on this co yet with the positive released phase 1 data on Zen3694. lets hope something good is cooking in the oven

Share
New Message
Please login to post a reply